Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

Over the last two decades, the frontline therapy for mantle cell lymphoma (MCL) has evolved. However, the impact of subsequent lines of therapy on survival outcomes has not been well characterized. In this study, we investigated the treatment patterns and survival outcomes in patients with relapsed/...

Descripción completa

Detalles Bibliográficos
Autores principales: Bock, Allison M., Gile, Jennifer J., Larson, Melissa C., Poonsombudlert, Kittika, Tawfiq, Reema K., Maliske, Seth, Maurer, Matthew J., Kabat, Brian F., Paludo, Jonas, Inwards, David J., Ayyappan, Sabarish, Link, Brian K., Ansell, Stephen M., Habermann, Thomas M., Witzig, Thomas E., Nowakowski, Grzegorz S., Cerhan, James R., Farooq, Umar, Wang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643454/
https://www.ncbi.nlm.nih.gov/pubmed/37957158
http://dx.doi.org/10.1038/s41408-023-00942-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643454/
https://www.ncbi.nlm.nih.gov/pubmed/37957158
http://dx.doi.org/10.1038/s41408-023-00942-3

Ejemplares similares